2003至2020年英格兰溃疡性结肠炎内科与外科治疗的时间趋势
基于英格兰2003-2020年新诊断溃疡性结肠炎患者33,464例的队列研究,采用Kaplan-Meier法计算结肠切除和用药累积发生率,Cox回归分析手术与死亡风险。结果显示5年择期和急诊结肠切除率分别从2.97%和3.90%降至1.59%和2.67%,晚期治疗使用率从2.53%升至16.71%,术后90天死亡率择期1.47%、急诊3.81%。
要点
- 5年择期结肠切除率从2.97%降至1.59%,急诊从3.90%降至2.67%。
- 5年晚期治疗使用率从2.53%升至16.71%。
- 术后90天死亡率择期1.47%、急诊3.81%。
核心结论
- 新诊断溃疡性结肠炎患者5年内结肠切除率下降,与晚期治疗使用增加同时发生。
- 术后总体死亡率低,当前实践数据令人安心。
研究设计与样本
- 基于计算机化健康记录识别2003-2020年新诊断溃疡性结肠炎患者33,464例的队列研究。
- 采用Kaplan-Meier法计算结肠切除和用药累积发生率,并比较3个时间段。
- 采用生命表法计算术后90天死亡率,Cox回归模型分析手术和死亡风险并校正混杂因素。
主要发现
- 5年择期结肠切除累积发生率从2003-2007年的2.97%降至2015-2020年的1.59%。
- 5年急诊结肠切除累积发生率从2003-2007年的3.90%降至2015-2020年的2.67%。
- 2015-2020年对比2003-2007年,择期手术aHR 0.47,急诊手术aHR 0.60。
- 女性择期手术aHR 0.73、急诊手术aHR 0.71;40-59岁者急诊手术aHR 0.87(对比18-39岁)。
- 5年晚期治疗使用率从2003-2007年的2.53%升至2015-2020年的16.71%。
关键数值与推荐
- 5年择期结肠切除累积发生率:2003-2007年2.97%,2015-2020年1.59%。
- 5年急诊结肠切除累积发生率:2003-2007年3.90%,2015-2020年2.67%。
- 择期手术aHR 0.47,急诊手术aHR 0.60(2015-2020 vs 2003-2007)。
- 女性择期aHR 0.73、急诊aHR 0.71;40-59岁急诊aHR 0.87(vs 18-39岁)。
- 5年晚期治疗使用率:2003-2007年2.53%,2015-2020年16.71%;90天死亡率择期1.47%、急诊3.81%。
临床怎么用
- 晚期治疗使用增加与结肠切除率下降相关,支持在溃疡性结肠炎中更积极应用晚期治疗。
- 术后90天死亡率低,可为手术决策提供 reassuring 的预后信息。
- 结肠切除指征可能影响不良结局风险,需结合个体情况评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The medical management of ulcerative colitis (UC) is evolving. However, colectomy may be required in severe or refractory cases. AIM: To provide contemporary evidence on medication usage and surgery for UC. METHODS: An incident cohort of patients newly diagnosed with UC from 2003 to 2020 was identified using computerised health records. The cumulative incidence of colectomy and medication use was calculated using Kaplan-Meier methods and compared across 3 time periods. We calculated 90-day post-operative mortality using life tables. Cox regression was used to model the risks of surgery and mortality, adjusting for confounders. RESULTS: 33,464 subjects had an incident diagnosis of UC. 5- year cumulative incidence of elective colectomy reduced from 2.97% to 1.59%, and emergency colectomy from 3.90% to 2.67% from 2003-2007 to 2015-2020. For elective surgery, adjusted hazard ratio (aHR) 0.47 and for emergency surgery, aHR 0.60 when 2015-2020 was compared to 2003-2007. Colectomy was less likely in women (elective aHR 0.73, emergency aHR 0.71) and emergency colectomy was less likely in those aged 40-59, aHR 0.87 than in those aged 18-39. Ninety- day mortality for elective and emergency surgery was 1.47% and 3.81%, respectively. Use of advanced therapies increased from 2.53% to 16.71% at 5 years from diagnosis when comparing 2003-2007 and 2015-2020. CONCLUSION: Colectomy in the five years following diagnosis has declined, coinciding with an increased use of advanced therapies. Overall post-operative mortality is low. While the indication for colectomy may influence the risk of adverse outcomes, aggregate data provide a reassuring picture of current practice.
引用
- Couch J, Thomas K, Card TR, et al. Temporal Trends in Medical and Surgical Management of Ulcerative Colitis in England: 2003-2020. Aliment Pharmacol Ther. 2025. PMID: 40778808. doi:10.1111/apt.70319
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。